MT-ND2 pseudogene 16 (MTND2P16)

MT-ND2 pseudogene 16 (MTND2P16) is a human pseudogene related by sequence to the mitochondrial gene MT-ND2, which encodes a subunit of the NADH:ubiquinone oxidoreductase (Complex I) of the respiratory chain. As a pseudogene, MTND2P16 is not expected to encode a functional protein, does not have a known biological function, and is not considered a drug target, enzyme, receptor, or transporter. There is no evidence for its relevance as a therapeutic target or as a biomarker in current literature[2][4][5]. The gene symbol and approved nomenclature for this locus is “MTND2P16”[4]. MTND2P16 is classified as a pseudogene, meaning it is a non-functional genomic element related by sequence to a functional gene (in this case, MT-ND2)[2][4]. It is not cited as having any enzymatic, receptor, transporter, or transcription factor functions, nor is it associated with roles like signal transduction, apoptosis, immune response, or other core biological processes. There is no current evidence—functional, therapeutic, or clinical—supporting any disease roles, drug interactions, mechanisms of action, biomarker utility, or safety concerns for MTND2P16 specifically[2][4][5]. Some mitochondrial pseudogenes may show differential expression in disease contexts such as Alzheimer's disease, but there is no evidence specifically implicating MTND2P16 in pathogenesis or as a therapeutic, diagnostic, or research target[5]. This entry is “incorrect” as a drug target because pseudogenes, including MTND2P16, are by definition not targets for direct modulation by drugs, nor do they encode proteins that serve canonical receptor/enzyme/transporter/transcription factor roles[2][4].

Other names

MTND2P16mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 pseudogene 16